AI summary Trust: medium Third-party lab

LabE tested this Tirzepatide batch at 99.95% purity via HPLC, mass quantification, and endotoxins. The tested quantity of 78.3mg significantly exceeded the 60mg label, a deviation of 30.5%. The endotoxin status is unknown, and the test is older (6-12 months). Customers can cross-check on the lab's public verification URL.

Watch out for
  • quantity deviation (30.5%)
  • no endotoxin status
  • older (6-12 months)
Test date
2025-08-05
Purity
99.95% 99.95%
Batch / lot
(no batch ID)
Lab
LabE
Quantity
label 60mg tested 78.3mg
Qty vs label
+30.5%
Endotoxins
—
Test score
4.9
Manufacturer
Qing Li Peptide
View vendor dossier
Certificate

Test report image

Certificate scan
Certificate scan as published.
Source

Finnrick

✓ Artifact captured

We have the certificate image (SHA-256 hash captured) — you can verify it loads from the upstream lab and matches the artifact below.

Verify on upstream
Method
HPLC + mass quantification + endotoxins
Test type
finnrick_composite
Dose
60mg
Container
No Label / Silver Crimp / Red Cap
Catalogued
2026-04-16
Artifact hash
39f6da53e6e7de0b…
This COA is part of TitrateLab's community-trust corpus. See more from Qing Li Peptide or learn how trust scores are computed on the methodology page.